TrialJournal of clinical immunology2011
H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses.
Philippe Moris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
92 papers cite itlatest 60 shown
this papertrialcites it